BioHorizons, a medical technology company that manufactures dental implants for the replacement of missing teeth, announced terms for its IPO on Tuesday. The Birmingham, AL-based company plans to raise $90 million by offering 5.6 million shares at a price range of $15-$17. At the mid-point of the proposed range, BioHorizons will command a market value of $315 million. BioHorizons, which was founded in 1995 and booked $78 million in sales for the 12 months ended September 30, 2010, plans to list on the NASDAQ under the symbol BHZN. Piper Jaffray and Jefferies & Co. are the lead underwriters on the deal, which is expected to price during the week of January 31.
